Test a vax, fly to Mexico

Want to go to Central America for free? All it takes is your participation in a linkurl:clinical trial for a diarrhea vaccine.;http://www.trekstudy.com/europe/index.html A patch worn on the arm can earn you a complimentary trip to one of nine cities in Mexico and Guatemala, courtesy of linkurl:Intercell AG.;http://www.intercell.com/main/ Image: Wikimedia commons, Andrew HitchcockThe Austrian drug company is recruiting 1800 volunteers for the phase III clinical trial of a vaccine against enterot

Written byJef Akst

| 2 min read

Save for Later

Image: Wikimedia commons,
Andrew Hitchcock

The Austrian drug company is recruiting 1800 volunteers for the phase III clinical trial of a vaccine against enterotoxigenic Escherichia coli -- a major cause of traveler's diarrhea, which affects about 20 million visitors to countries such as Africa, Asia and Latin America, as well as illness in more than 200 million children living in those countries each year. If approved, it would be the first vaccine for traveler's diarrhea available in the US. A couple years ago, we looked at the question of linkurl:how researchers and companies decide on compensation;http://www.the-scientist.com/2008/2/1/38/1/ for subjects' participation in clinical trials. But the trip offered by the Austrian company seems to be an entirely new recruitment tactic, the linkurl:BMJ reports.;http://www.bmj.com/cgi/content/extract/340/jan05_2/c49 Intercell joined forces with linkurl:Inclinix, Inc.,;http://www.inclinix.com/ a North Carolina-based clinical trial enrollment solutions provider, to devise a strategy including partnerships with major travel and tourism websites, as well as a variety of social networking outlets, including linkurl:Twitter;http://twitter.com/trekstudy and linkurl:YouTube.;http://www.youtube.com/watch?v=wYqkbXdsl-c "Social communication avenues allow Inclinix to reach a unique audience," Diane Montross, director of patient recruitment for Inclinix, told linkurl:Medical News Today.;http://www.medicalnewstoday.com/articles/135977.php "We are defining the next patient recruitment landscape." In addition to the flight to Central America, participants will receive at least six nights of three star accommodations, pre-paid mobile phones, welcome kits with useful travel tools, and $1,500 upon completion of the study. Participants will be given either the active vaccine or a placebo before travel, give blood within 48 hours of arrival, keep a stool diary throughout their trip, and provide additional blood and stool samples if they develop diarrhea. Correction: The original version of this story stated that the compensation for this study is paid in cash, when in fact it is given in the form of prepaid credit cards. The Scientist regrets the error.
**__Related stories:__***linkurl:UK to boost clinical trial participation;http://www.the-scientist.com/blog/display/54769/
[25th June 2008]*linkurl: Paying for Patients;http://www.the-scientist.com/2008/2/1/38/1/
[ February 2008]*linkurl:Should trial sponsors pay for treatment?;http://www.the-scientist.com/blog/display/54264/
[31st January 2008]

Meet the Author

Jef Akst

Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

View Full Profile

Test a vax, fly to Mexico

The Scientist ARCHIVES

Become a Member of

Meet the Author

Jef Akst

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Skip the Wait for Protein Stability Data with Aunty

Products

Product News

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform